Bafna Pharmaceuticals IPO vs MCX IPO

Comparision between Bafna Pharmaceuticals IPO and MCX IPO.

IPO Details

Bafna Pharmaceuticals IPO is a Mainline Book Built Issue IPO proposed to list at BSE while MCX IPO is a Mainline Book Built Issue proposed to list at BSE.

	Bafna Pharmaceuticals IPO	MCX IPO
Logo
Issue Category	Mainline	Mainline
Issue Type	IPO	IPO
Process Type	Fixed Price Issue	Book Built Issue
Listing At	BSE	BSE
Lead Managers	Keynote Financial Services Ltd Ashika Capital Ltd	Citigroup Global Markets India Private Limited Edelweiss Financial Services Ltd Morgan Stanley India Company Pvt Ltd
Registrar	Cameo Corporate Services Limited	Kfin Technologies Limited
Market Maker
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Bafna Pharmaceuticals IPO is up to ₹25.60 Cr whereas the issue size of the MCX IPO is up to ₹663.31 Cr. The final issue price of Bafna Pharmaceuticals IPO is ₹40.00 per share and of MCX IPO is ₹1,032.00 per share.

	Bafna Pharmaceuticals IPO	MCX IPO
Face Value	₹10 per share	₹10 per share
Issue Price (Lower)		₹860.00 per share
Issue Price (Upper)		₹1,032.00 per share
Issue Price (Final)	₹40.00 per share	₹1,032.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size		6 shares
Fresh Issue Size
Fresh Issue Size (Amount)
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total	64,00,000 shares	64,27,378 shares
Issue Size Total (Amount)	up to ₹25.60 Cr	up to ₹663.31 Cr

IPO Timetable

Bafna Pharmaceuticals IPO opens on May 27, 2008, while MCX IPO opens on Feb 22, 2012. The closing date of Bafna Pharmaceuticals IPO and MCX IPO is May 30, 2008, and Feb 24, 2012, respectively.

	Bafna Pharmaceuticals IPO	MCX IPO
Anchor Bid Date
Issue Open	May 27, 2008	Feb 22, 2012
Issue Close	May 30, 2008	Feb 24, 2012
Basis Of Allotment (Tentative)
Initiation of Refunds (Tentative)
Credit of Share (Tentative)
Listing date (Tentative)
Anchor Lockin End date 1
Anchor Lockin End date 2

Financials

Bafna Pharmaceuticals IPO P/E ratio is , as compared to MCX IPO P/E ratio of .

Bafna Pharmaceuticals IPO

MCX IPO

Financial

Particulars	For the year/period ended (Rs. in lacs)
	30-Jun-07	31-Mar-07	31-Mar-06	31-Mar-05	31-Mar-04
Total Income	432.02	3861.96	2136.47	2662.65	1521.33
Profit After Tax (PAT)	49.70	104.23	92.27	89.81	44.51

Particulars	For the year/period ended (in Rs. Million)
	31-Dec-11	31-Mar-11	31-Mar-10	31-Mar-09
Total Income	4,745.02	4,475.60	4,937.01	3,658.44
Profit After Tax (PAT)	2,205.34	1,730.97	2,207.26	1,574.19

Read MCX Annual Reports

Promoter Shareholding (Pre-Issue)

71.07%

31.18%

Promoter Shareholding (Post-Issue)

42.6%

26%

P/E Ratio

Market Cap

ROE

ROCE

Debt/Equity

EPS

RoNW

10.65%%

20.77%%

Shares Offered

In the Bafna Pharmaceuticals IPO retail investors (RII) are offered while in MCX IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Bafna Pharmaceuticals IPO and 21,62,083 shares in MCX IPO.

	Bafna Pharmaceuticals IPO	MCX IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB		21,62,083 shares
NII		9,26,607 shares
RII		21,62,082 shares
Employee		2,50,000 shares
Others
Total		55,00,772 shares

Bids Received (Subscription)

Bafna Pharmaceuticals IPO subscribed in total, whereas MCX IPO subscribed 54.13x.

	Bafna Pharmaceuticals IPO	MCX IPO
QIB (times)		49.12x
NII (times)		150.35x
Big NII (times)
Small NII (times)
RII (times)		24.14x
Employee (times)		0.18x
Other (times)
Total (times)		54.13x

Compare with others

Bafna Pharmaceuticals IPO	MCX IPO
Archidply IPO	Lotus Eye Care IPO
First Winner IPO	Archidply IPO
Sejal IPO	First Winner IPO
Avon Weighing IPO	Sejal IPO
MCX IPO	Avon Weighing IPO
Niraj Cement Structurals IPO	Bafna Pharmaceuticals IPO
Anu Laboratories IPO	Niraj Cement Structurals IPO
Gokul Refoils IPO	Anu Laboratories IPO
Aishwarya Telecom IPO	Gokul Refoils IPO
Titagarh Wagons IPO	Aishwarya Telecom IPO

Comments

Add a public comment...